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Supporting materials and methods 
 
Construction of plasmids and strains. All point mutants were produced with the 
QuickChange Site-Directed Mutagenesis Kit (Agilent) and all constructs produced by PCR 
were confirmed by sequencing. To generate the plasmid encoding for amine oxidase promoter 
(PAMO) driven Pex11p, tagged N-terminally with GFP (LMO.GFP-HpPex11), the plasmids 
pENTR/41-PAMO GFP, pENTR-221-PEX11, pENTR23/Tamo and pDEST-NAT were 
recombined by a Gateway LR reaction, resulting in plasmid LMO.GFP.HpPex11. The 
resulting vector was linearized with AdeI and transformed into H. polymorpha cells.  
The E. coli expression vector for the RING domain of Pex2p (pCW261) was made as 
follows: PCR was performed on H. polymorpha genomic DNA using primers HpP2 246 NcoI 
(F) and HpP2 330 HIII (R) and the resulting fragment was digested with NcoI and HindIII and 
ligated into NcoI-HindIII digested pETM30. To produce the E. coli expression vector of 
Dnm1p, PCR was performed on pSNA02 using primers DNM1 1 PciI (F) and DNM1 753 
NotI (R) and the resulting PCR product was digested with PciI and HindIII and ligated into 
NcoI-HindIII digested pETM30.  
pHIPZ17-Nia, the plasmid containing the Pex11 promoter (PPEX11) was constructed as 
follows: to isolate the PEX11 promoter a fragment of 0.9 kb upstream the PEX11 gene was 
amplified using primer pex11-1 and pex11-2 and genomic DNA as template. The resulting 
fragment was digested with HindIII and NotI and ligated in HindIII-NotI digested pHIPZ4-
Nia(1) resulting in vector pHIPZ17-Nia. 
To obtain WT Pex11p under control of the endogenous promoter (PPEX11) complete 
with C-terminal His6 tag, PCR was performed on LMO.GFP.HpPex11 with the primer pair 
Pex11 HIII (F) and Pex11-His SalI (R). The resulting fragment was digested with HindIII and 
SalI and ligated into HindIII-SalI digested pHIPZ17-Nia, resulting in the vector pCW323. The 
resulting vector was linearized with BstAPI and transformed into H. polymorpha cells. To 
produce Pex11-His6 under control of the alcohol oxidase promoter (PAOX), pCW323 was 
digested with HindIII and SalI and the digested product was ligated into HindIII-SalI digested 
pHIPZ4-Nia. The resulting vector, pCW329, was linearized with NsiI prior to transformation 
into H. polymorpha cells.  
All H. polymorpha Pex11p point mutants were constructed using pCW323 as template 
and the primer pairs described in Table S3. The resulting vectors were digested with BstAPI 
prior to transformation into H. polymorpha cells. The vector for overexpressing Pex11p 
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L15A/L59A, complete with C-terminal His6-tag, was made by digesting pCW340 with 
HindIII and SalI and the resulting fragment was ligated into HindIII-SalI digested pHIPZ4. 
The resulting vector, pCW342, was linearized with NsiI and transformed into H. polymorpha 
cells.  
pex11Δ cells expressing DNM1-GFP in under control of its own promoter (PDNM1) or 
the amine oxidase promoter (PAMO) were produced as follows: plasmids pSNA01 (PDNM1) and 
pSNA02 (PAMO) were linearized with BstI and NarI, respectively, and transformed into H. 
polymorpha pex11Δ cells. The dnm1Δ overexpressing PEX11 was produced as follows: 
plasmid pHIPZ4 PEX11 was linearized with NsiI and transformed into H. polymorpha cells.  
Transformation of H. polymorpha was performed as described (2). Transformants 
were selected based on their ability to grow on YPD medium supplemented with 100 µg/ml 
nourseothricin or zeocin (Invitrogen). All integrations were confirmed by colony polymerase 
chain reaction (PCR). 
Mammalian Pex11β point mutants were produced using pcDNA3 containing human 
PEX11 β as template (3) and the primer pairs listed in Table S3.   
 
Cell extracts and general biochemical techniques. Crude extracts of H. polymorpha cells 
were prepared as described (4). Specific polyclonal antibodies directed against H. polymorpha 
Pex11p, dihydroxyacetone synthase (DHAS), Elongation factor 1α, H. polymorpha Dnm1p 
(Fig. S9), S. cerevisiae Dnm1p (a kind gift from J. Nunnari, University of California), the 
His6-tag (Santa Cruz Biotechnology) and the GST tag (Pierce antibodies) and monoclonal 
antibodies against GFP (Santa Cruz Biotechnology) were used.  
 Lysates of transfected COS-7 cells were prepared by addition of lysis buffer (10 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5 % NP40, 0.5 % Triton X-100,  1 mM 
PMSF and Protease Inhibitor Cocktail (Roche Applied Sciences)) followed by incubation at 
4°C with rotation for 15 min. Insoluble material was pelleted by centrifugation at 15,000g for 
15 min and the supernatant collected. The subsequent western blots were probed with 
antibodies directed against the Myc-tag (mouse monoclonal, epitope 9E10, Santa Cruz 
Biotechnology) and α-tubulin (mouse monoclonal, Sigma-Aldrich).  
 
Expression and purification of proteins from E. coli. H. polymorpha Dnm1p and Pex2 
RING domain, complete with cleavable His6-GST tag, were produced in the E. coli strain 
BL21 (DE3) RIL. Cells were grown at 37°C to an OD600 of 1.5 in Terrific Broth (TB) 
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medium supplemented with antibiotics, transferred to 21°C and grown further until an OD600 
of 2.0. Protein expression was then induced with 1 mM IPTG (Invitrogen) for 16 h and cells 
were harvested by centrifugation. E. coli cell pellets expressing His6GST-Dnm1p or His6GST-
Pex2 RING were thawed in Dnm1 lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM 
MgCl2, 5 % glycerol, 2 mM β-mercaptoethanol, 2 mM PMSF, pH 7.4), treated with 1 mg/ml 
lysozyme and then passed through a French press. Cell debris was removed by centrifugation 
and lysates were loaded onto glutathione sepharose-4B resin (GE Healthcare) pre-equilibrated 
with Dnm1 lysis buffer. The resin was extensively washed with Dnm1 lysis buffer and His6-
GST tagged proteins were eluted with Dnm1 lysis buffer containing 20 mM reduced 
glutathione. For in vitro pull down assays, His6GST-Pex2 RING was gel filtrated into Dnm1 
storage buffer (25 mM Tris pH 7.4, 150 mM NaCl, 10 mM MgCl2, 5 % glycerol, 1 mM β-
mercaptoethanol) with a Superdex 75 (16/60) column (GE Healthcare). For peptide blot 
analysis, His6GST-Dnm1p was passed over a Superose 6 (10/300) column equilibrated with 
Dnm1 storage buffer.  
For in vitro pull down and GTPase activity experiments using Dnm1p, the His6GST 
tag was removed by cleavage with His6-TEV (ratio TEV:His6GST-Dnm1p 1:25) and the 
sample was applied to Ni-NTA resin to remove the His6GST tag, TEV and undigested fusion 
protein. Dnm1p was purified further by gel filtration on a Superose 6 (10/300) column 
equilibrated with Dnm1 storage buffer. Purified Dnm1p was also used to develop polyclonal 
antibodies against H. polymorpha Dnm1p in rabbits (Eurogentec).  
Human Drp1 isoform 2 complete with N-terminal His6 tag was produced the E. coli 
strain BL21 (DE3) RIL. Cells were grown at 37°C to an OD600 of 0.4 in Terrific Broth (TB) 
medium supplemented with antibiotics, transferred to 18°C and grown further until an OD600 
of 1.5. Protein expression was then induced with 40 M IPTG (Invitrogen) for 16 h and cells 
were harvested by centrifugation. His6-Drp1 was purified as described in (5) but the His6 tag 
was not removed, to allow detection using anti-His6 antibodies. The protein was finally gel 
filtrated into 20 mM HEPES, 300 mM NaCl, 2.5 mM MgCl2, 2.5 mM dithiothreitol, pH 7.5.  
Purity of recombinant proteins was monitored by SDS PAGE analysis and protein 
concentration was estimated using a Nanodrop
TM
 (www.nanodrop.com). 
 
Binding assays. For co-immunoprecipitation, cells (50 A600 units) were lysed with glass 
beads in 500 μl lysis buffer (phosphate buffer saline (PBS) pH 8, 0.5% IGEPAL, 1 mM 
PMSF, 1 mM 2-mercaptoethanol) at 4°C. Debris was removed by centrifugation and lysates 
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were incubated with 5 μl anti-Dnm1p at 4°C. After 2 h, Protein A‐Sepharose beads (GE 
Healthcare) were added and lysates were incubated for 1 h at 4°C. Precipitates were washed 
twice with lysis buffer and once with PBS and elution was carried out in 50 μl 125 mM Tris, 
pH 6.8, 1.5% SDS, 20% glycerol for 5 min at 95°C. Samples were then split in two and to one 
fraction 5 % (final concentration) 2-mercaptoethanol was added, to reduce disulphide bonds 
present in the IgGs, aiding Dnm1p detection. Samples were analysed by SDS–PAGE and 
immunoblotting.  
For in vitro pull downs, purified His6GST-Pex2 RING or Pex11-His6 variants were 
incubated with Ni-NTA resin for 30 min at 4
o
C with gentle rotation in Pex11p storage buffer. 
Columns were washed with Pex11p storage buffer and incubated with purified Dnm1p for 1 h 
at 4
o
C with gentle rotation. Columns were washed with Pex11p storage buffer and elution was 
performed with Pex11p storage buffer containing 500 mM imidazole. Samples were analysed 
by SDS-PAGE and western blotting. 
 
Expression and purification of Pex11p from H. polymorpha cells. H. polymorpha cells 
harbouring WT and L15A/L59A forms of Pex11-His6 were grown for 16 h on mineral media 
containing 0.05 % glycerol and 0.5 % methanol. Cells were harvested by centrifugation (10 
min, 6,000 rpm), resuspended in Hp lysis buffer (50 mM Tris-HCl, 300 mM NaCl, 10 mM 
imidazole pH 8.0) with Complete protease inhibitors (Roche) and disrupted using a French 
Press. Membrane fractions were separated from soluble proteins by centrifugation (10,000 x g 
for 1 h at 4
o
C) and membrane proteins were extracted from the pellet fractions by gentle 
stirring in Hp washing buffer 1 (50 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 5 % 
glycerol, 0.2 % IGEPAL CA-630, pH 8.0) for 1 h at 4
o
C. Extracted proteins were recovered 
by centrifugation (10,000 x g at 4
o
C for 1 h) and the supernatant was incubated with Ni-NTA 
resin (Qiagen) for 1 h at 4
o
C. The column was extensively washed with Hp washing buffer 1 
and 2 (50 mM Tris-HCl, 600 mM NaCl, 40 mM imidazole, 5 % glycerol, 0.2 % IGEPAL CA-
630, pH 8.0) and bound proteins were eluted with elution buffer (50 mM Tris-HCl, 300 mM 
NaCl, 250 mM imidazole, 5 % glycerol, 0.1 % IGEPAL CA-630, pH 8.0). Finally, Pex11-
His6 proteins were passed through HiTRAP
TM
 desalting columns (GE Healthcare) 
equilibrated with Pex11p storage buffer (25 mM Tris-HCl, 150 mM NaCl, 20 mM imidazole, 
5 % glycerol, 0.1 % IGEPAL CA-630, pH 8.0). The purification process was monitored with 
SDS-PAGE and coomassie brilliant blue staining (Fig. 3B). Pex11-His6 concentration was 
determined using the RC/DC Protein Assay kit (Bio-Rad).  
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 Purification of Pex11-His6 for use in in vitro GTPase assays was performed in 
essentially the same manner except that DDM (GLYCON Biochemicals GmbH) was used as 
detergent instead of IGEPAL. The buffer used to extract Pex11-His6 from membrane fractions 
contained 1 % DDM, whereas all other buffers contained 0.03 %.  
 
Binding of His6GST-Dnm1p and Drp1 to peptide blots. In vitro binding of purified 
His6GST-Dnm1p or His6GST to the cellulose membrane-bound Pex11p peptides was 
analysed as follows: peptide arrays were blocked with blocking buffer (Casein Blocking 
Buffer (Sigma) containing 5 % saccharose) for 3 h at room temperature (RT). After washing 
with Tris buffer (50 mM Tris HCl, 300 mM NaCl, 10 mM MgCl2 and 10 % Glycerol, pH 8), 
the arrays were incubated with His6GST-Dnm1p or His6GST in blocking buffer (50 µg/ml) 
overnight at 4°C. The arrays were washed with Tris buffer and incubated first with mouse 
anti-poly His tag antibody (H1029, Sigma) at RT for 2 h, followed by HRP-labelled anti-
mouse antibody (A5906, Sigma) at RT for 1.5 h. Visualization of membrane-bound proteins 
was carried out using a chemiluminescence substrate (UptiLight, Uptima) and a Lumi-Imager 
(RocheDiagnostics). Analyses of SPOT signal intensities was performed with the software 
Genespotter (Micro-Discovery, Berlin, Germany). To assess the binding of Dnm1p to WT and 
a mutant form of the amphipathic helix of Pex11p, where Leu59, Leu62 and Phe63 were 
altered to Alanines, a dilution series of the peptides in TBS (10 mM Tris-HCl, 150 mM NaCl) 
was spotted onto nitrocellulose. The blot was allowed to dry and then blocked in TBS 
containing 2 % (w/v) milk powder for 1 h at RT. After extensive washing with Tris buffer, the 
blot was incubated with Dnm1p (50 µg/ml) in Tris buffer containing 0.25 % milk powder 
overnight at 4°C. The blot was extensively washed with Tris buffer and probed using 
antibodies directed against H. polymorpha Dnm1p.  
 The binding of Drp1 to WT and the W4A mutant form of helix 1 from Pex11β was 
performed as described above, except that due to their hydrophobicity, peptides were 
dissolved 50 % ethanol prior to being spotted onto nitrocellulose and the resulting blot, after 
incubation with purified Drp1, was probed using Penta·His antibodies (Qiagen). Peptide 
concentrations were determined using the RC/DC Protein Assay kit (Bio-Rad).  
 
GTPase activity measurements. Reactions containing Dnm1p (0.8 µM), with or without 
Pex11p peptides (8 µM) or purified Pex11-His6 (3 µM) were performed in 25 mM Tris pH 
7.4, 150 mM NaCl, 5 mM MgCl2, 1 % glycerol, 1 mM β-mercaptoethanol at 37°C. When 
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Pex11-His6 was added, reactions also contained 0.03 % DDM. Reactions were pre-incubated 
at room temperature for 30 min, followed by 5 min at 37 °C and were initiated by the addition 
of GTP. Samples were taken at the indicated time points and terminated by the addition of 
Gold lock reagent. After 5 min incubation, stabilizer was added and the reaction was 
incubated for 30 min at room temperature to allow the colour to develop. Phosphate release 
was determined by measuring the absorbance of the reaction mixtures at 635 nm using a 
Multiskan™ GO Microplate Spectrophotometer (Thermoscientific). Values were background 
subtracted and compared to a standard phosphate curve. For time course analysis, reactions 
were initiated by the addition of 100 µM GTP. For steady-state kinetic analysis on Dnm1p, 
GTP assays were performed with variable concentrations of GTP (0, 50, 100, 250, 500, 750 
and 1,000 µM) and samples were removed every 5 min for 20 min to determine the initial 
velocity. GTPase activity measurements conducted with purified Drp1 (0.4 µM), in the 
presence or absence of Pex11p peptides (4 µM) were conducted in essentially the same way 
as with Dnm1p, except that reactions were performed in 25 mM Tris pH 7.4, 150 mM NaCl, 5 
mM MgCl2 and the GTP concentrations used for steady-state kinetic analysis were 0, 50, 100, 
200, 400, 800 and 1,600 µM. 
 
Extraction of peroxisomal membrane proteins. The behaviour of Pex11p upon extraction 
of organellar fractions by different reagents was analysed using fractions enriched in 
peroxisomes as starting material (6). Organellar fractions (150 μg of protein) were extracted 
sequentially with 0.1 M Tris pH 8.0 followed by 0.1 M Tris, 1 M NaCl pH 8.0 and 0.1 M 
Na2CO3  pH 11.5. After the incubations membrane pellets were obtained by 
ultracentrifugation (15 min at 100,000 x g at 4
o
 C). Both supernatant and pellet fractions were 
precipitated with 12.5 % TCA. The resulting samples were analysed by SDS-PAGE and 
western blotting using antibodies directed against Pex11p and DHAS.   
 
Fluorescence microscopy on COS-7 cells. Microscopy analysis was performed using an 
Olympus IX81 microscope (Olympus Optical) equipped with a PlanApo 100x/1.40 oil 
objective and filter sets 41020 and 41004 (Chroma). Images were acquired with a 
Photometrics CoolSNAP HQ2 CCD camera (Roper Scientific, Germany) driven by 
MetaMorph software (MDS Analytical Technologies). Antibodies used are as follows: rabbit 
polyclonal antibodies against Pex14p (kindly provided by D. Crane, Griffith University) and 
Drp1 (7) and mouse monoclonal anti-myc (Santa Cruz Biotech). Species-specific anti-IgG 
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antibodies conjugated to the fluorophoresent Alexa 594 and Alexa 488 were obtained from 
BioRad (Richmond) and Invitrogen (Life Technologies). 
 
Quantification of peroxisomes and statistical analysis of data. Peroxisome numbers were 
quantified in the yeast  H. polymorpha using fluorescence and brighfield microscopy images. 
Cells were detected with a custom-made plugin for ImageJ. Using the brightfield image slices 
as input, the cells are approximated by a 3-dimensional ellipsoid. For the detection of 
peroxisomes, another plugin was developed. This plugin uses the data from the fluorescent 
channel and was designed to parse clumps of peroxisomes. For this, clumps of connected 
peroxisomes are isolated on each z-slice. Next, the outline of each peroxisome clump is 
described by a chain of interconnected nodes. Concave regions in the chain indicate a 
transition between two adjacent peroxisomes. The convex regions between these transitions 
are then used to fit circles. Finally, the data from all the z-slices are combined, and the 
separate peroxisomes are described as spheres. 
For quantitative evaluation of organelle morphology in mammalian cells, 100-200 
cells per coverslip were examined by fluorescence microscopy and categorized accordingly. 
Usually, three coverslips per preparation were analysed, and at least three independent 
experiments were performed.  
The number of peroxisome profiles based on electron microscopy images was 
estimated from at least 200 randomly selected cell sections. Numbers correspond to the 
average number of peroxisome profiles per cell section +/- standard deviation across two 
separate EM grids. In addition, the number of peroxisomes per cell was quantified using serial 
sections of  20 randomly selected cells per strain. 
Significant differences between experimental groups were detected by analysis of 
variance for unpaired variables using Microsoft Excel and GraphPad Prism 5 software. Data 
are presented as means ± SEM, with a two-tailed unpaired t-test used to determine statistical 
differences. P values <0.05 are considered as significant, and P values <0.01 are considered 
as highly significant.  
 
Fluorescence Protease Protection assay. For the analysis of the membrane topology of H. 
polymorpha Pex11p, cells producing DsRed-SKL and either GFP-Pex11 or Pex11-GFP were 
grown for 16 h in mineral media supplemented with glycerol/methanol (to induce production 
of DsRed-SKL) and methylamine (for induction of expression of the GFP fusion proteins). 
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Organellar fractions were isolated according to (6) and analysed by fluorescence microscopy. 
Organellar fractions (2 mg/ml of total proteins) were supplemented with trypsin (2 mg/ml), 
incubated for 1 h at 4°C and analysed by fluorescence microscopy. The decrease in the 
intensities of GFP and DsRed fluorescence was measured using ImageJ software for at least 
50 organelles and the average ratio of GFP/DsRed fluorescence was plotted. 
 
Supporting results 
 
Hansenula polymorpha Pex11p is an integral component of the peroxisomal membrane. 
Previous reports have demonstrated that Pex11p is an integral membrane protein in humans 
and trypanosomes (8, 9) yet Pex11p from S. cerevisiae appears to be a peripheral membrane 
protein (10). Therefore, we analysed the topology of H. polymorpha Pex11p, to gain insight 
into the structural properties of the protein (Fig. S2A). To this end, purified organellar 
fractions, enriched for mitochondria and peroxisomes, were subjected to high salt or high pH 
treatment. Pex11p was not extracted from peroxisomes treated with 1 M NaCl or sodium 
carbonate (pH 11.5) while under these conditions, the peroxisomal matrix protein 
dihydroxyacetone synthase (DHAS) was detected in supernatant fractions, indicating that 
Pex11p from H. polymorpha is an integral membrane protein, like its human and 
trypanosomal counterparts.  
To study the orientation of the N- and C- termini of Pex11p in vivo, a Fluorescence 
Protease Protection assay (FPP) was used (11). In the FPP assay the plasma membrane of 
cells producing Pex11p, fused N- or C- terminally to GFP, together with the matrix marker 
DsRed-SKL, was selectively permeabilised with digitonin. These cells were subsequently 
treated with protease to digest all cytosolic accessible content, whereas internal organellar 
constituents are protected by the organelle membrane. Organelle fractions of cells producing 
DsRed-SKL and GFP-Pex11 or Pex11-GFP (both localize to the peroxisome membrane, Fig. 
S2B) were isolated, treated with Proteinase K and analysed by fluorescence microscopy. A 
strong reduction of GFP fluorescence was observed for both GFP-Pex11 and Pex11-GFP in 
comparison to DsRed fluorescence (Fig. S2C) suggesting that both termini of Pex11p are 
located on the cytosolic surface of the peroxisomal membrane.  
 
Helix 1 of Pex11β can stimulate the GTPase activity of Drp1 in vitro. To determine 
whether mammalian Pex11β, like its H. polymorpha counterpart, also possessed GAP 
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activity, we assessed the effect of peptides derived from Pex11β on the GTPase activity of 
Drp1. To achieve this, we produced two peptides of Pex11β: the first peptide corresponding to 
the first 12 amino acids of Pex11β, which we termed Pex11β helix 1. This peptide covers the 
region of Pex11β that demonstrates high sequence and secondary structure homology with 
that of binding site B1 from H. polymorpha Pex11p (Fig. S3). The second corresponded to 
amino acids 40 to 75, which we termed Pex11β Amph, and was designed to cover the region 
in Pex11β that is highly similar to the amphipathic helix of H. polymorpha Pex11p. Addition 
of Pex11β Amph did not affect the activity of Drp1 in vitro (Fig. S7C) whereas inclusion of 
Pex11β helix 1 caused a small increase in the GTPase activity of Drp1. This peptide also 
binds to Drp1 in vitro (Fig. S8B). To investigate whether this apparent increase represented a 
significant gain in activity, we determined the kinetic parameters of Drp1 in the presence and 
absence of Pex11β helix 1 (Fig. S7D & E). Purified Drp1 (Fig. S7B) displayed a maximum 
velocity (Vmax) of 1.63 ± 0.03 µM Pi released min
-1
. Recently, Bustillo-Zabalbeitia et al (12) 
reported a similar value for the Vmax of Drp1 (1.6 µM Pi released min
-1
). Addition of the 
peptide Pex11β helix 1 resulted in a small but significant (p<0.01) increase in the Vmax of 
Drp1 (Fig. S7E), establishing that Pex11β possesses the ability to stimulate the GTPase 
activity of Drp1.  
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Table S1. Quantification of peroxisome numbers using fluorescence microscopy 
 
Strain Average no. peroxisomes per cell* 
pex11Δ 0.73 ± 0.25 
WT 4.39 ± 0.03 
L15A 4.19 ± 0.04 
L59A 4.50 ± 0.38 
L15A/L59A 2.94 ± 0.04 
*
Average of two independent cultures. At least 1300 cells were counted per culture. 
 
 
Table S2. Plasmids used in this study 
 
Name Description Reference 
pEXP-PEX11-GFP 
pDESTTM R4-R3 NAT with HpPEX11-GFP under control of amine oxidase promoter 
(PAMO), Amp
R 
(13) 
pENTR-221-PEX11 pDONRTM 221 with HpPEX11 cDNA without a stop codon; KanR (1) 
pENTR/41-PAMO GFP pDONR
TM P4-P1R with PAMOGFP, Kan
R (14) 
pENTR23/TAMO Gateway vector containing AMO terminator (TAMO) (14) 
pDEST-NAT pDESTTM R4-R3 with nourseothricin marker, AmpR  (1) 
LMO.GFP-HpPex11 pDEST-NAT containing PAMO GFP-HpPEX11 TAMO, Amp
R, NatR  This study 
pHIPZ4 PEX11 Plasmid containing PAOX HpPEX11 (15) 
pCW261 His6GST HpPex2 RING domain, for expression in E. coli; Kan
R This study 
pCW283 His6GST HpDnm1p, for expression in E. coli; Kan
R This study 
pSKB-LNB Drp1 
Modified pET28a plasmid containing His tagged Human Drp1 (isoform 2), for E. coli 
expression, KanR. 
(5) 
pCW323 Plasmid containing PPEX11 HpPEX11 with C-terminal His6-Tag; Amp
R, ZeoR This study 
pCW329 Plasmid containing PAOX HpPEX11 with C-terminal His6-Tag; Amp
R, ZeoR This study 
pCW332 Plasmid containing PPEX11 HpPEX11 L59A, with C-terminal His6-Tag; Amp
R, ZeoR This study 
pCW339 Plasmid containing PPEX11 HpPEX11 L15A with C-terminal His6-Tag; Amp
R, ZeoR This study 
pCW340 Plasmid containing PPEX11 HpPEX11 L15A/L59A with C-terminal His6-Tag; Amp
R, ZeoR This study 
pCW342 Plasmid containing PAOX HpPEX11 L15A/L59A with C-terminal His6-Tag; Amp
R, ZeoR This study 
pSNA01 Plasmid containing C-terminal part of DNM1 fused to GFP, AmpR, ZeoR (13) 
pSNA02 Plasmid containing PAMODNM1-GFP.TAMO, Amp
R, ZeoR (13) 
pMCE7 Plasmid containing C-terminal part of PMP47 fused to GFP; AmpR; ZeoR (16) 
pcDNA3 Plasmid containing HsPex11β-Myc for mammalian expression (3) 
pcDNA3 W4A Plasmid containing HsPex11β-Myc W4A mutant, for mammalian expression This study 
pcDNA3 L48A Plasmid containing HsPex11β-Myc L48A mutant, for mammalian expression This study 
pcDNA3 W4A/L48A Plasmid containing HsPex11β-Myc W4A/L48A mutant, for mammalian expression This study 
pHIPZ4-Nia Plasmid containing PAOX Nia, Amp
R, ZeoR (17) 
pHIPZ17-Nia Plasmid containing PPEX11 Nia, Amp
R, ZeoR This study 
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Table S3. Oligonucleotides used in this study 
 
Name Sequence (5’ – 3’) 
HpP2 246 NcoI (F) GCCATGGCTGATCAGAAACAGGATGAAAAGG 
HpP2 330 HIII (R) GCGAAGCTTTAGCCGTCGAACACCCGCACAAAC 
DNM1 1 PciI (F) GCGCGCGCACATGTCGGCATTGCAAGACC 
DNM1 753 NotI (R) GCGCGCGCGCGGCCGCTTAAACAACTTCGCTAATGATAG 
Pex11-1 ATAAGAATGCGGCCGCGTGGACTGCTACGAGACATT 
Pex11-2 CCCAAGCTTATAACTGTCTGTCTGTCCC 
Pex11 HIII (F) GCGCGCGCAAGCTTATGGTTTGCGACACGATAAC 
Pex11-His SalI (R) GCGCGCGCGTCGACTCAGTGATGGTGATGGTGATGTAGCACAGAAGACTCGGTC 
Pex11 L15A (F) CCGACTCTCACGAAAGCGATCAACTTCCTCGAGAC 
Pex11 L15A (R) GTCTCGAGGAAGTTGATCGCTTTCGTGAGAGTCGG 
Pex11 L59A (F) CATTACTATCTGGTGAGAAGAGCGCAGGATTTGTTCACGC 
Pex11 L59A (R) GCGTGAACAAATCCTGCGCTCTTCTCACCAGATAGTAATG 
Pex11_W4AFor AAGCTT GGTACC ATGGACGCCGCCGTCCGCTTCAGTGCTCAGAGC 
Pex11_W4ARev GCTCTGAGCACTGAAGCGGACGGCGGCGTCCAT GGTACC AAGCTT 
Pex11_L48AFor TACAGAAACAGATTCGACAAGCCGAGAGCCACCTGAGCCTTGG 
Pex11_L48ARev CCAAGGCTCAGGTGGCTCTCGGCTTGTCGAATCTGTTTCTGTA 
 
 
Table S4. H. polymorpha strains used in this study 
 
Strain Characteristics Reference 
Wild type  NCYC 495 (18) 
pex11Δ PEX11 deletion strain (15) 
dnm1Δ DNM1 deletion strain (13) 
WT + PDNM1 DNM1-GFP Wild type cells with pSNA01 (13) 
WT + PAMO DNM1-GFP Wild type cells with pSNA02 (13) 
pex11Δ + PDNM1 DNM1-GFP pex11Δ cells with pSNA01 This study 
pex11Δ + PAMO DNM1-GFP pex11Δ cells with pSNA02 This study 
dnm1Δ + PAOX PEX11 dnm1Δ cells with pHIPZ4 PEX11 This study 
pex11Δ + PAOX PEX11-His6 pex11Δ cells with pCW329 This study 
pex11Δ + PMP47-GFP pex11Δ cells with pMCE7 This study 
pex11Δ + PMP47-GFP + WT Pex11-His6 pex11Δ + PMP47-GFP cells with pCW323 This study 
pex11Δ + PMP47-GFP + Pex11-His6 L15A pex11Δ + PMP47-GFP cells with pCW339 This study 
pex11Δ + PMP47-GFP + Pex11-His6 L59A pex11Δ + PMP47-GFP cells with pCW332 This study 
pex11Δ + PMP47-GFP + Pex11-His6 L15A/L59A pex11Δ + PMP47-GFP cells with pCW340 This study 
DsRed-SKL Wild type cells with  PAOX DsRed-SKL (19) 
DsRed-SKL + PAMO PEX11-GFP DsRed-SKL cells with pEXP-PEX11-GFP This study 
DsRed-SKL + PAMO GFP-PEX11 DsRed-SKL cells with LMO.GFP-HpPex11 This study 
pex11Δ + PAOX PEX11-His6 L15A/L59A pex11Δ cells with pCW342 This study 
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Supporting figure legends 
 
Fig. S1. Overproduction of Dnm1p or Pex11p. (A) Quantification of peroxisome profiles in 
thin sections of the strains depicted in Fig. 1. At least 200 cell sections were used for 
quantification. Numbers represent the mean number of peroxisomal profiles per section ± 
standard deviation across two separate EM grids (* p<0.05, n.s. statistically not significant). 
(B) Quantification of peroxisome numbers in serial EM sections of 20 randomly selected 
pex11Δ cells and pex11Δ cells overproducing Dnm1-GFP. Numbers represent the mean ± 
standard deviation across the cells (n.s. statistically not significant). (C) Western blots of 
lysates prepared from WT and pex11Δ cells expressing DNM-GFP under control of its own 
promoter (-) or the amine oxidase promoter (+DNM1, for overproduction of Dnm1-GFP) 
probed with antibodies against GFP and Elongation factor 1α (loading control). As control a 
lysate of cells lacking DNM1 (dnm1Δ) is also depicted. (D) Western blots of lysates prepared 
from dnm1Δ cells expressing PEX11 under control of its own promoter (-) or under the 
alcohol oxidase promoter (+PEX11, for overproduction of Pex11p) probed with Pex11p and 
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pyruvate carboxylase (Pyc, loading control) antibodies. As control a lysate of cells lacking 
PEX11 (pex11Δ) is also depicted. 
 
Fig. S2. Topology of H. polymorpha Pex11p. (A) Organellar fractions isolated from WT H. 
polymorpha cells were sequentially extracted with 0.1 M Tris pH 8.0, 0.1 M Tris 1 M NaCl 
pH 8.0 and 0.1 M Na2CO3 pH 11.5. In between each extraction step, fractions were subjected 
to ultracentrifugation. Samples were analysed with SDS-PAGE and Western blotting using 
antibodies against dihydroxyacetone synthase (DHAS) and Pex11p. DHAS is used as soluble 
matrix marker (B) Fluorescence microscopy analysis of methanol grown cells producing 
DsRed-SKL, to mark peroxisomes, and either GFP-Pex11 (left panels) or Pex11-GFP (right 
panels). Scale bar: 5 μm. (C) Organellar fractions isolated from cells producing DsRed-SKL 
and GFP-Pex11 or Pex11-GFP were incubated with trypsin (2 mg/ml) for 1 h on ice and 
analysed by fluorescence microscopy. The intensities of GFP and DsRed fluorescence were 
measured for at least 50 organelles and the average ratios of GFP to DsRed signals without 
protease treatment (controls, arbitrarily set to 100 %) and after proteolysis were plotted. Error 
bars represent standard deviation.  
 
Fig. S3. Sequence and structural properties of H. polymorpha Pex11p. (A) Domain 
organisation of H. polymorpha Pex11p, displaying the predicted α-helices (H), 
transmembrane domains (TMD) and the four putative binding Dnm1p binding sites (B1-B4) 
identified using the peptide blot analysis (Fig. 4). Numbers depict amino acid positions. (B) 
Sequence alignment of H. polymorpha Pex11p together with a selection of homologous 
Pex11p sequences. Black shading indicates identity and grey shading similarity when present 
in at least four of the eight sequences aligned. Sc, Saccharomyces cerevisiae; Pp, Pichia 
pastoris; Pc, Penicillium chrysogenum; Hs, Homo sapiens; Tb, Trypanosoma brucei. 
Mutating the residues depicted with an asterisk in H. polymorpha Pex11p disturbs the 
interaction between Pex11p peptides and Dnm1p (Fig. 4). (C) Sequence alignment of the 
predicted α-helices that incorporate the Dnm1p binding sites in Pex11p (Helix 1; residues 12-
19, Amph helix; residues 55-87). Black shading indicates identity and grey shading similarity. 
Mutating the residues depicted with an asterisk (Helix 1) or open triangle (Amph helix) 
disturbs the interaction between Pex11p peptides and Dnm1p (Fig. 4). (D) Using the 
sequences of the Dnm1p binding peptides, 3D models of ideal α-helices were built that 
correspond to the identified Dnm1p binding sites in Pex11p and superimposed using VMD 
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(20). The α-helix containing binding site B1 (Helix 1, residues 12-19) is depicted in magenta, 
while the α-helix containing binding site B3 (Amph helix, residues 55-74) in green. The 
termini of the helices are labelled.  
 
Fig. S4. Pex11 L15A/L59A causes increased numbers of cells with 1 or 0 peroxisomes 
and exhibits reduced binding to Dnm1p without compromising growth on methanol 
containing media. (A) Quantification of peroxisome numbers in pex11Δ, WT and 
L15A/L59A cells grown on methanol. Values represent the mean ± standard error of mean of 
two independent experiments, with 1000 cells counted in each experiment. The frequency 
distributions of cells with number of peroxisomes per cell are shown. (B) In vitro pull down 
assay using purified Dnm1p together with Pex11-His6 or Pex11 L15A/L59A-His6 bound to 
Ni-NTA resin. After washing, proteins were eluted from the column using imidazole and 
analysed by SDS-PAGE and western blotting using antibodies directed against Dnm1p and 
Pex11p. Elution fractions are 4 times concentrated relative to Input and Flow through 
fractions. (C) Glucose grown pex11Δ cells or pex11Δ cells expressing WT or L15A/L59A 
forms of Pex11p under control of the Pex11p promoter were shifted to methanol containing 
media and the optical density (OD) at 600 nm was measured at the indicated time points. 
Graphs represent the mean ± standard deviation of four separate experiments.  
 
Fig. S5. Purified Pex11-His6 stimulates the GTP activity of Dnm1p in vitro. Time course 
of GTP hydrolysis by Dnm1p alone (closed circles), Dnm1p in the presence of purified 
Pex11-His6 (closed diamonds), Pex11-His6 (triangles) or buffer alone (crosses). Where absent, 
the detergent DDM was added to a final concentration of 0.03 %, to mimic reactions that 
included purified Pex11-His6. For comparison, a time course depicting GTP hydrolysis by 
Dnm1p in the absence of DDM (open circles, Dnm1p w/o DDM) is included.  
 
Fig. S6. GTP hydrolysis by Dnm1p in the presence and absence of Pex11p peptides. (A) 
Time course of GTP hydrolysis by Dnm1p alone (open circles), or in the presence of Pex11p 
peptides corresponding to binding site B1 (open diamonds), binding site B3 (crosses) and the 
amphipathic helix of Pex11p (closed squares). (B) GTP hydrolysis by Dnm1p in the absence 
(diamonds) or presence (triangles) of the amphipathic helix of Pex11p, in low (closed 
symbols, black lines) or high salt (open symbols, grey lines) buffer. (C) GTP hydrolysis by 
Dnm1p alone (open circles), Dnm1p in the presence of the amphipathic helix of Pex11p 
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(closed squares) or a mutant form of the amphipathic helix of Pex11p lacking residues 
involved in the Dnm1p interaction (closed triangles). (D) In vitro binding of Dnm1p to the 
amphipathic helix of Pex11p (Pex11p Amph) and a mutant form lacking residues involved in 
the Dnm1p interaction (Pex11p AAA). After the peptides were spotted onto a nitrocellulose 
membrane (amounts per spot are indicated above the blot), the blot was incubated with 
purified Dnm1p and probed with antibodies directed against H. polymorpha Dnm1p. 
 
Fig. S7. Helix 1 of mammalian Pex11β stimulates the GTPase activity of Drp1 in vitro. 
(A) Domain organisation of H. sapiens Pex11β, displaying the predicted α-helices (H) and 
transmembrane domains (TMD). The regions of Pex11β corresponding to the peptides used in 
subsequent studies, termed Helix 1 (residues 1 to 12) and Amph helix (residues 40 to 75) are 
indicated. Numbers depict amino acid positions. (B) SDS-PAGE and coomassie staining 
analysis of Drp1 purified from E. coli. (C) Time course of GTP hydrolysis by Drp1 (open 
circles), Drp1 together with a peptide of the amphipathic helix of Pex11β (closed squares) or 
Drp1 together with a peptide of helix 1 of Pex11β (closed diamonds). (D) Steady state 
kinetics of GTP hydrolysis by Drp1 in the presence (closed squares) and absence (open 
circles) of the helix 1 peptide from Pex11β. (F) Kinetic parameters of Drp1 in the presence 
and absence of the helix 1 peptide from Pex11β. Values represent the mean ± standard 
deviation of three separate measurements (** p<0.01).   
 
Fig. S8. The W4A mutation in Pex11β does not alter Drp1 localisation but inhibits the 
Pex11β-Drp1 interaction in vitro. (A) Drp1 localises in spots on elongated peroxisomes 
induced by Pex11β-W4A. COS-7 cells were transfected with Pex11β-Myc (A-D) or Pex11β-
W4A-Myc (E-H). After 48 h cells were fixed and labelled with anti-Myc (B, F) and anti-Drp1 
(C, G) antibodies. (A-D) Pex11β-Myc promotes peroxisome division. Endogenous Drp1 co-
localises with Pex11β-Myc at small spherical and elongated peroxisomes (arrows). (E-H) 
Pex11β-W4A interferes with peroxisome division and result in the accumulation of highly 
elongated peroxisomes. Endogenous Drp1 localises in spots to Pex11β-W4A-positive 
elongated peroxisomes (arrows). Higher magnification view of boxed regions (B-D, F-H). 
Scale bar: 10 μm. (I) Binding of Drp1 to peptides corresponding to helix 1 of Pex11β (Pex11β 
Helix 1) and a mutant form where the Tryptophan residue at position 4 is mutated to an 
Alanine (Pex11β Helix 1 W4A). After the peptides were spotted onto a nitrocellulose 
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membrane (amounts per spot are indicated above the blot), the blot was incubated with 
purified Drp1 and probed with antibodies directed against the His6 tag present on Drp1. 
 
Fig. S9. Specificity of H. polymorpha Dnm1p antibodies. Western blots of lysates of WT 
cells, dnm1Δ cells and WT cells overproducing Dnm1-GFP, together with purified Dnm1p 
from E. coli, probed with pre-immune sera (left panel) or sera isolated from a rabbit 
immunogenized with purified Dnm1p (right panel).  
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